GlassScriptPrepare for your visit
Aleena Banerji
Allergy & Immunology · Boston, MA · NPI 1063495562
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$133,081.41
in general payments reported to CMS, 2019-2025 · $13K in 2025
The $13K reported for 2025 was more than what 90% of Allergy & Immunology providers received nationally (typical 2025 total: $1,138).
Who reported paying
General payments only, top 6 by amount.
- Csl Behring $45,056.97
- Shire North American Group INC $27,985.61
- Biocryst Pharmaceuticals, INC. $24,781.17
- Takeda Pharmaceuticals U.S.A., INC. $20,233.75
- Biocryst US Sales Co., LLC $8,088.94
- Pharming Healthcare, INC. $6,150.97
Drugs and devices associated with these payments
Andembry Orladeyo Takhzyro
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Aleena Banerji listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/3385/aleena-banerji